30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Tony Hunt

Track

Insider profile

Currently holds a position at Repligen Corp

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
121 1% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 16%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
President, Chief Executive Officer, Director Repligen Corp May 21, 2015 -
Chief Operating Officer, Treasurer Repligen Corp May 9, 2014 - May 21, 2015
Chief Operating Officer Repligen Corp May 5, 2014 - May 9, 2014
Tony Hunt's trades of Repligen Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
47,726 -15.2%
59.63
US$764,187 		47,726 -15.2% 59.63 US$764,187
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
23,063 +41.0%
276.62
US$343,549 		23,063 +41.0% 276.62 US$343,549
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
21,905 +38.8%
110.12
US$4,986,060 		21,905 +38.8% 110.12 US$4,986,060
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
2,500 -2.7%
154.32
US$385,800 		2,500 -2.7% 154.32 US$385,800
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
2,923 -3.0%
153.14
US$447,628 		2,923 -3.0% 153.14 US$447,628
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
2,100 -2.1%
152.17
US$319,557 		2,100 -2.1% 152.17 US$319,557
2025-11-14 2025-11-13
US Repligen Corp (RGEN)
S Sale
1,784 -1.8%
151.01
US$269,402 		1,784 -1.8% 151.01 US$269,402
2025-11-13 2025-11-13
US Repligen Corp (RGEN)
PrS Proposed sale
20,000
154.62
US$3,092,327 		20,000 154.62 US$3,092,327
2025-11-13 2025-11-12
US Repligen Corp (RGEN)
S Sale
464 -0.5%
158.51
US$73,549 		464 -0.5% 158.51 US$73,549
2025-11-13 2025-11-12
US Repligen Corp (RGEN)
S Sale
11,096 -9.9%
158.01
US$1,753,279 		11,096 -9.9% 158.01 US$1,753,279
2025-11-13 2025-11-12
US Repligen Corp (RGEN)
S Sale
4,959 -4.2%
156.65
US$776,827 		4,959 -4.2% 156.65 US$776,827
2025-11-13 2025-11-12
US Repligen Corp (RGEN)
S Sale
4,740 -3.9%
155.85
US$738,729 		4,740 -3.9% 155.85 US$738,729
2025-11-13 2025-11-12
US Repligen Corp (RGEN)
S Sale
3,741 -3.0%
154.92
US$579,556 		3,741 -3.0% 154.92 US$579,556
2025-11-12 2025-11-12
US Repligen Corp (RGEN)
PrS Proposed sale
25,000
156.88
US$3,921,981 		25,000 156.88 US$3,921,981
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
2,179 -2.1%
122.23
US$266,339 		2,179 -2.1% 122.23 US$266,339
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
7,584 -6.9%
121.42
US$920,849 		7,584 -6.9% 121.42 US$920,849
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
14,882 -11.9%
120.19
US$1,788,668 		14,882 -11.9% 120.19 US$1,788,668
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
3,262 -2.5%
119.64
US$390,266 		3,262 -2.5% 119.64 US$390,266
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
1,108 -0.9%
118.32
US$131,099 		1,108 -0.9% 118.32 US$131,099
2025-09-11 2025-09-10
US Repligen Corp (RGEN)
S Sale
96 -0.1%
116.34
US$11,169 		96 -0.1% 116.34 US$11,169
2025-09-10 2025-09-10
US Repligen Corp (RGEN)
PrS Proposed sale
29,111
120.52
US$3,508,378 		29,111 120.52 US$3,508,378
2025-05-16 2025-05-15
US Repligen Corp (RGEN)
S Sale
7 -0.0%
127.00
US$889 		7 -0.0% 127.00 US$889
2025-05-16 2025-05-15
US Repligen Corp (RGEN)
S Sale
268 -0.2%
125.20
US$33,554 		268 -0.2% 125.20 US$33,554
2025-05-16 2025-05-15
US Repligen Corp (RGEN)
S Sale
6,533 -5.6%
124.34
US$812,313 		6,533 -5.6% 124.34 US$812,313
2025-05-16 2025-05-15
US Repligen Corp (RGEN)
S Sale
17,596 -13.1%
123.57
US$2,174,338 		17,596 -13.1% 123.57 US$2,174,338
2025-05-16 2025-05-15
US Repligen Corp (RGEN)
S Sale
2,043 -1.5%
122.66
US$250,594 		2,043 -1.5% 122.66 US$250,594
2025-05-15 2025-05-15
US Repligen Corp (RGEN)
PrS Proposed sale
26,447
128.34
US$3,394,208 		26,447 128.34 US$3,394,208
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
2,283 -1.6%
153.70
US$350,897 		2,283 -1.6% 153.70 US$350,897
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
15,619 -10.1%
152.82
US$2,386,896 		15,619 -10.1% 152.82 US$2,386,896
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
6,176 -3.9%
151.96
US$938,505 		6,176 -3.9% 151.96 US$938,505
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
2,518 -1.5%
151.09
US$380,445 		2,518 -1.5% 151.09 US$380,445
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
100 -0.1%
150.38
US$15,038 		100 -0.1% 150.38 US$15,038
2025-03-19 2025-03-17
US Repligen Corp (RGEN)
S Sale
60 -0.0%
148.05
US$8,883 		60 -0.0% 148.05 US$8,883
2025-03-17 2025-03-17
US Repligen Corp (RGEN)
PrS Proposed sale
26,756
150.42
US$4,024,638 		26,756 150.42 US$4,024,638
2024-11-22 2024-11-21
US Repligen Corp (RGEN)
S Sale
24,246 -14.8%
139.67
US$3,386,439 		24,246 -14.8% 139.67 US$3,386,439
2024-11-21 2024-11-21
US Repligen Corp (RGEN)
PrS Proposed sale
24,246
139.66
US$3,386,311 		24,246 139.66 US$3,386,311
2024-09-12 2024-09-10
US Repligen Corp (RGEN)
S Sale
604 -0.4%
146.67
US$88,589 		604 -0.4% 146.67 US$88,589
2024-09-12 2024-09-10
US Repligen Corp (RGEN)
S Sale
10,723 -7.1%
145.95
US$1,565,022 		10,723 -7.1% 145.95 US$1,565,022
2024-09-12 2024-09-10
US Repligen Corp (RGEN)
S Sale
9,369 -5.8%
144.88
US$1,357,381 		9,369 -5.8% 144.88 US$1,357,381
2024-09-12 2024-09-10
US Repligen Corp (RGEN)
S Sale
1,495 -0.9%
143.77
US$214,936 		1,495 -0.9% 143.77 US$214,936
2024-09-10 2024-09-10
US Repligen Corp (RGEN)
PrS Proposed sale
22,191
144.72
US$3,211,481 		22,191 144.72 US$3,211,481
2024-06-14 2024-06-14
US Repligen Corp (RGEN)
B Purchase
2,000 +1.2%
124.08
US$248,160 		2,000 +1.2% 124.08 US$248,160
2024-05-22 2024-05-21
US Repligen Corp (RGEN)
S Sale
969 -0.6%
171.03
US$165,728 		969 -0.6% 171.03 US$165,728
2024-05-22 2024-05-21
US Repligen Corp (RGEN)
S Sale
3,925 -2.3%
170.04
US$667,407 		3,925 -2.3% 170.04 US$667,407
2024-05-22 2024-05-21
US Repligen Corp (RGEN)
S Sale
2,963 -1.7%
169.27
US$501,547 		2,963 -1.7% 169.27 US$501,547